Regulatory aspects of fumonisins in the United States.
The hazards and risks from fumonisins, a relatively recently discovered class of mycotoxins, are in the process of being characterized. Any risk management approach must consider the uncertainties in the risk characterization and practicalities of control options. This paper addresses risk management alternatives, especially in the context of the Food and Drug Administration's legal authorities, and the potential impacts of the alternatives.